n
This research proposed an architecture for a ubiquitous healthcare system called HeartPals and used
the proposed TOFUSER as its feasibility study scheme to verify the early requirements of HeartPals
design while gaining other useful requirements obtained through the process of qualitative analysis with
potential users. The output of this study will assist in the development phases of HeartPals where the
innovators and developers must include users’ requirements right from the feasibility study phase to
enable the end product to be precisely suited to the market needs. For future work, we are currently
focusing on developing the prototype version of HeartPals focusing in the mobile environment without
deploying the Physiological Signal Devices (PSD) yet. An extensive research in establishing safety,
reliability and effectiveness for both the application and devices are also being conducted. Furthermore, a
legal and ethical clearance from the medical authority will also be sought. We are looking forward to
further discussions on the prototype evaluation outcome with actual users and subsequently, to develop
the full solution with PSD included and, finally, proceed to clinical trial for proving the effectiveness of
the overall solution.
TOFUSER, hence, enabling the product innovators to gain users’ verification of the preliminary
product/system requirements. Therefore, the innovators will be able to reach meaningful information on
how the product will affect the users as well as to verify whether the product/system idea is realizable.
nThis research proposed an architecture for a ubiquitous healthcare system called HeartPals and usedthe proposed TOFUSER as its feasibility study scheme to verify the early requirements of HeartPalsdesign while gaining other useful requirements obtained through the process of qualitative analysis withpotential users. The output of this study will assist in the development phases of HeartPals where theinnovators and developers must include users’ requirements right from the feasibility study phase toenable the end product to be precisely suited to the market needs. For future work, we are currentlyfocusing on developing the prototype version of HeartPals focusing in the mobile environment withoutdeploying the Physiological Signal Devices (PSD) yet. An extensive research in establishing safety,reliability and effectiveness for both the application and devices are also being conducted. Furthermore, alegal and ethical clearance from the medical authority will also be sought. We are looking forward tofurther discussions on the prototype evaluation outcome with actual users and subsequently, to developthe full solution with PSD included and, finally, proceed to clinical trial for proving the effectiveness ofthe overall solution.TOFUSER, hence, enabling the product innovators to gain users’ verification of the preliminaryproduct/system requirements. Therefore, the innovators will be able to reach meaningful information onว่าผลิตภัณฑ์จะมีผลต่อผู้ใช้เช่นเพื่อตรวจสอบว่า ความคิดสินค้าระบบ realizable
การแปล กรุณารอสักครู่..